ACC Live Courses
For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings


RSS Latest in Cardiology from ACC.org

  • First Medical Contact in ACS: NCDR and the Latest Guidelines
    A recent JACC: Advances Viewpoint examines the challenges associated with implementing revisions to the definition of first medical contact (FMC) introduced in the 2025 ACC/AHA ACS Guideline and its implications for NCDR data collection, specifically for the ACC's Chest Pain – MI Registry.
  • SirPAD Redefines Drug-Coated Balloon Therapy in PAD
    Peripheral artery disease (PAD) affects >113 million people worldwide and remains a major cause of limb loss, cardiovascular morbidity, and cardiovascular mortality.
  • Twenty-Five Years Later: Remembering Sept. 11
    Today marks 25 years since Sept. 11, 2001 – a day forever etched into our collective memory. For those of us who lived through that morning, it can seem both a lifetime ago and only yesterday.
  • ACC, STS and SCAI Issue Joint Statement on TAVR National Coverage Determination
    The American College of Cardiology (ACC), Society of Thoracic Surgeons (STS) and Society for Cardiovascular Angiography & Interventions (SCAI) released the following joint statement on the transcatheter aortic valve replacement (TAVR) national coverage determination finalized by the Centers for Medicare and Medicaid Services (CMS).
  • Look AHEAD: IL-6, Not hs-CRP, Identifies Risk of HF in Patients With T2D, Overweight/Obesity
    The inflammatory biomarker interleukin (IL)-6 identified residual inflammatory risk of incident heart failure (HF) in patients with type 2 diabetes (T2D) and overweight/obesity, particularly among those with no history of cardiovascular disease, according to results of a Look AHEAD ancillary study published Sept. 3 in JACC: Heart Failure.